| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4ad61d0af1fd483d31d1c5df9b9b76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_441f7c6829d19d1f693aa6ad677f2e8d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 |
| filingDate |
2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f95eadd883e2f28a40acabd59c7b35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39a7baf017eb26526f154841c8011889 |
| publicationDate |
2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020085534-A1 |
| titleOfInvention |
Composition comprising sod3-overexpressed, cord blood-derived stem cell as active ingredient for prevention or treatment of atopic dermatitis |
| abstract |
The present invention relates to a pharmaceutical composition comprising superoxide dismutase 3 (SOD3)-overexpressed, cord blood stem cells as an active ingredient for prevention or treatment of atopic dermatitis. The composition according to the present invention exhibits an inhibitory effect against the degranulation of mast cells, which play as a core etiological factor in atopic dermatitis and as such, can be advantageously used to prevent or treat atopic dermatitis. |
| priorityDate |
2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |